While emerging from general anesthesia may seem a straightforward process, helping patients—both healthy and with complications—to “Open Your Eyes” is the mission of OYE Therapeutics. Delayed emergence from anesthesia is costly to both the patient and the healthcare system; one study showed the condition causes 32,000 deaths each year and $9.3 billion annually in added […]... Read More
Industry experts say Indiana is emerging as a powerful hub for nuclear medicine, and the most recent fuel to be added to the fire is Telix Pharmaceuticals earning approval from the U.S. Food and Drug Administration to launch its first commercial product. The radiopharmaceuticals sector, also known as nuclear medicine, is gathering momentum in central […]... Read More
A recent DNA discovery means four Hoosier high school students are published scientists at the young age of 18. While COVID wreaked havoc on students’ senior years, Noblesville High School teacher Caitlyn Foye got creative with the closures and brought cutting-edge research to her classroom. The students uncovered four new gene sequences—a discovery so rare […]... Read More
Triple negative breast cancer (TNBC) is a devastating form of breast cancer that has left researchers scrambling to find weapons against its high recurrence rate, lower survival rate than other forms of the disease and confusion about how to best treat it—and Indiana is leading the charge. As a nerve center for TNBC research, the […]... Read More
In the same way that precision medicine has revolutionized the treatment of cancer, it could also radically improve how patients are treated for depression, says Carmel-based startup Gate Neurosciences Inc. In oncology, precision medicine enables doctors to analyze the biology of the patient’s tumor, then prescribe drugs that are most powerful against that specific type […]... Read More
After more than a decade of work, Purdue University-based On Target Laboratories Inc. has claimed the “holy grail” of biotech startups; just days ago, the U.S. Food and Drug Administration approved CYTALUX, a surgical innovation for cervical cancer from the lab of Purdue’s Dr. Philip Low, who has launched seven companies and sold Endocyte for […]... Read More
A new material invented by a professor at the University of Notre Dame for spinal implants is likely just months away from being used on the first patients. Implants used for spinal fusion have long been made out of a polymer called PEEK, because it’s “a good material” with excellent mechanical properties, says Notre Dame […]... Read More
The biggest vaccination campaign in history is creating new pressures in logistics, and an Indianapolis-based company is responding by building a distribution facility designed specifically for the shifting demands of the life sciences industry. Langham Logistics says the new distribution center—the company’s first one north of Indianapolis—will also support a recent explosion of life sciences […]... Read More
The global market for 3D printed medical devices is expected to grow by $2.3 billion in the next four years, says a global technology research company. While 3D printed medical devices encompass a variety of devices, it was orthopedic and spinal 3D printing that took the largest slice of the revenue “pie” in 2020. With […]... Read More
Despite the urgency of treating a heart attack, the process of diagnosing one can seem painstakingly slow. In most cases, when a patient comes to the emergency room with symptoms of a heart attack, doctors will order a troponin test. However, the test measures a marker that can take up to six hours after a […]... Read More
